BDSX - BIODESIX INC

0.549
-0.005   -0.838%

Share volume: 348,529
Last Updated: 04-17-2025
Healthcare/Services – Health: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.55
0.00
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
38%
Profitability 35%
Dept financing 38%
Liquidity 35%
Performance 43%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.26%
1 Month
-28.10%
3 Months
-48.69%
6 Months
-65.90%
1 Year
-56.08%
2 Year
-70.64%
Key data
Stock price
$0.55
P/E Ratio 
0.00
DAY RANGE
$0.54 - $0.58
EPS 
-$0.33
52 WEEK RANGE
$0.51 - $2.04
52 WEEK CHANGE
-$56.08
MARKET CAP 
222.565 M
YIELD 
N/A
SHARES OUTSTANDING 
145.177 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$313,703
AVERAGE 30 VOLUME 
$325,369
Company detail
CEO: Scott Hutton
Region: US
Website: biodesix.com
Employees: 220
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules.

Recent news
loading